Cochrane Review Group
Skin
74 systematic reviews in Skin ask 1,886 questions. 28.7% have no studies to answer them, 17.3% rest on very low certainty evidence and 24.1% reach moderate or high certainty.
Reviews
74
Questions
1,886
current versions
No studies
28.7%
Moderate or high
24.1%
No studies 542 · 28.7%Ungraded 130 · 6.9%Very low 326 · 17.3%Low 434 · 23%Moderate 348 · 18.5%High 106 · 5.6%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Prednisone plus azathioprine vs prednisone Disease control (at 6 months) · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 0.93 [0.52, 1.66] | 1 study · 67 participants | Very low |
Prednisone plus azathioprine vs prednisone Mortality (at 6 months) · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 1.03 [0.35, 3.06] | 1 study · 67 participants | Very low |
Prednisone plus azathioprine vs prednisone Quality of life ‐ not measured · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | No studies |
Prednisone plus azathioprine vs prednisone Adverse events · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | Very low |
Nicotinamide plus tetracycline vs prednisone Disease control: complete response at 8 weeks: excluding dropouts · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 2.5 [0.37, 16.89] | 1 study · 18 participants | Very low |
Nicotinamide plus tetracycline vs prednisone Mortality at 6 months · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 0.18 [0.01, 3.85] | 1 study · 18 participants | Very low |
Nicotinamide plus tetracycline vs prednisone Quality of life ‐ not measured · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | No studies |
Nicotinamide plus tetracycline vs prednisone Adverse events at 1 year · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | Very low |
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Disease control (time when steroid could be discontinued) · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | 1 study · 54 participants | Very low |
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Mortality at 1 year · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | RR 0.33 [0.04, 3.01] | 1 study · 54 participants | Very low |
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Quality of life ‐ not measured · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | No studies |
Methylprednisolone plus azathioprine vs methylprednisolone plus dapsone Adverse events at 1 year · bullous pemphigoid Interventions for bullous pemphigoid (2023) · Cochrane | no estimate extracted | NR | Very low |
Reviews 74
Interventions for pityriasis rosea
CochraneSoF table
36 questions
Genetic testing for prevention of severe drug‐induced skin rash
CochraneSoF table
8 questions
Interventions for infantile seborrhoeic dermatitis (including cradle cap)
CochraneSoF table
9 questions
Non‐antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis
CochraneSoF table
5 questions
Antistreptococcal interventions for guttate and chronic plaque psoriasis
CochraneSoF table
25 questions
Lifestyle changes for treating psoriasis
CochraneSoF table
10 questions
Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema
CochraneSoF table
25 questions
Interventions for ulceration and other skin changes caused by nerve damage in leprosy
CochraneSoF table
100 questions
Interventions for preventing occupational irritant hand dermatitis
CochraneSoF table
8 questions
Probiotics for treating eczema
CochraneSoF table
6 questions
Interventions for infantile haemangiomas of the skin
CochraneSoF table
21 questions
Oral isotretinoin for acne
CochraneSoF table
3 questions
Systemic treatments for metastatic cutaneous melanoma
CochraneSoF table
40 questions
Leukotriene receptor antagonists for eczema
CochraneSoF table
14 questions
Interventions for necrotizing soft tissue infections in adults
CochraneSoF table
12 questions
Drugs for discoid lupus erythematosus
CochraneSoF table
25 questions
Interventions for cutaneous molluscum contagiosum
CochraneSoF table
7 questions
Interventions for Old World cutaneous leishmaniasis
CochraneSoF table
10 questions
Interventions for the prevention of recurrent erysipelas and cellulitis
CochraneSoF table
6 questions
Oral antifungal medication for toenail onychomycosis
CochraneSoF table
30 questions
Emollients and moisturisers for eczema
CochraneSoF table
63 questions
Systemic antifungal therapy for tinea capitis in children
CochraneSoF table
15 questions
Interventions for female pattern hair loss
CochraneSoF table
32 questions
Light therapies for acne
CochraneSoF table
15 questions
Specific allergen immunotherapy for the treatment of atopic eczema
CochraneSoF table
6 questions